Biota BTA51-350-201 - Symptomatic Influenza

• Research type

  Research Study

• Full title

  A Phase 2 Randomized, Double Blind, Placebo Controlled, Parallel Arm Study to Investigate the Efficacy and Safety of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in adults with Symptomatic Influenza A or B Infection.

• IRAS ID

  134138

• Contact name

  Nell Victoria Wyatt

• Contact email

  n.wyatt@nhs.net

• Sponsor organisation

  Biota Scientific Management Pty Ltd.

• Eudract number

  2013-000582-36

• Clinicaltrials.gov Identifier

  NCT01793883

• REC name

  South West - Central Bristol Research Ethics Committee

• REC reference

  13/SW/0245

• Date of REC Opinion

  4 Nov 2013

• REC opinion

  Further Information Favourable Opinion